IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q2 2020 Holdings

Filed 2020-08-14 | 16 holdings | $357.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte(PCVX)Common92243G108$131.5K4,168,71836.8%
Personalis(PSNL)Common71535D106$70.6K5,449,29419.7%
Phathom(PHAT)Common71722W107$39.4K1,203,13511.0%
Crispr(CRSP)NAMEN AKTH17182108$38.1K519,19810.6%
SolenoCommon834203200$22.8K10,302,6026.4%
Exicure(XCUR)Common30205M101$17.0K6,977,0004.7%
Sierra OncologyCommon82640U107$10.5K876,5412.9%
SientraCommon82621J105$9.2K2,390,8432.6%
ParatekCommon699374302$5.4K1,041,1311.5%
Verona(VRNA)SPONDS ADR925050106$4.2K901,9431.2%
Protara(TARA)Common74365U107$3.0K53,6120.8%
Molecular TemplatesCommon608550109$2.8K200,0000.8%
Aeglea(AGLEUSD)Common00773J103$2.2K240,5000.6%
ObsevaCommonH5861P103$51787,9990.1%
Cymabay(CBAYUSD)Common23257D103$456131,0360.1%
OcugenCommon43358V109$27,1110.0%